In-Vitro Diagnostics Quality Control Market Analysis Size 2018-2026 In-Vitro Diagnostics Quality Control Market

In-Vitro Diagnostics Quality Control Market Overview, Trends and
Forecast to 2026 Just Published
The latest market report published by Credence Research, Inc. “In-Vitro Diagnostics Quality Control
Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global in-vitro diagnostics
quality control market was valued at US$ 854.0 Mn in 2017 and expected to grow at compound annual
growth rate (CAGR) of 3.9% during the forecast period from 2018 to 2026.
Market Insights
The global in-vitro diagnostics quality control market is projected to grow at a steady rate during the
forecast period . The major reason for the growth of the market includes growing applications of in-vitro
diagnostics and point-of-care diagnostics for various diseases such as chronic diseases, infectious diseases
and oncology testing. Quick testing and accurate results have positioned in-vitro diagnostics testing in
modern healthcare. In-vitro diagnostics fall under medical devices category and hence Food and Drug
Administration (FDA), Medicines and Healthcare Products Regulatory Agency (MHRA) and other
regulatory bodies have implemented stringent regulatory process for maintaining the standard quality and
safety of the testing systems. This factor is the major growth driver for in-vitro diagnostics quality control
market. Increasing number of clinical and diagnostics laboratories worldwide is also influencing the market
growth. In terms of application, the market is led by clinical chemistry owing to growing application in
chronic diseases, most prominently in cancer treatment and cardiovascular treatment. Immunochemistry
also held a prominent share in the market due to urgent requirement for novel drug discovery and
increasing physician awareness regarding disease etiology will propel market penetration for
immunochemistry segment.
Don’t Miss the Sample @ https://www.credenceresearch.com/sample-request/59637
In terms of geography, North America accounted for the maximum share of in-vitro diagnostics quality
control market . North America is a domicile to major diagnostic laboratories and service providers. The
U.S. FDA and Health Canada have designed stringent quality control policies for IVD to maintain the safety
and accuracy of the tests. Growing government funded research and development to cater burden of
diseases will further drive the market in the region. Asia Pacific emerged as the fastest growing region
owing to growing usage of IVD testing and rising applications in the region. Surge in contract
manufacturing and research for drug discovery and clinical chemistry in the region will drive market.
Growing healthcare infrastructure and high unmet needs is attributable to growth of the market. Asia
Pacific Federation of Clinical Biochemistry and Laboratory Medicine supports the growth of IVD and
assures accuracy and safety of the testing systems.
The key players currently engaged in In-vitro diagnostics quality control market include Siemens
Healthineers, Thermo Fisher Scientific, Inc., Roche Diagnostics, Bio-Rad Laboratories, Inc., Abbott
Laboratories, Inc., Seracare Life Sciences, Inc., Sysmex Corporation, Helena Laboratories, Sun Diagnostics,
LLC among others.
Key Market Movements:
 Growing burden of chronic disorders, cancer and infectious diseases globally driving the demand
for in-vitro diagnostics quality control
 Stringent regulatory policies for maintaining the accuracy and safety of the IVD tests